pharmaphorum October 2, 2024
In a bold move to tackle soaring drug costs, Blue Shield of California is pioneering a strategy that bypasses traditional pharmacy benefit managers (PBMs) to bring blockbuster drugs to patients at a fraction of the cost. By partnering directly with manufacturers, the insurer aims to dramatically reduce the price of AbbVie’s Humira, the world’s top-selling drug, by up to 90%.
Blue Shield’s agreement with drug manufacturer Fresenius Kabi, an operating company of Fresenius, and Evio Pharmacy Solutions, which facilitated the deal, introduces a new model called Pharmacy Care Reimagined. This approach aims to eliminate the excessive markups often found in traditional PBM models, providing members with better access to biosimilar medications.
The company isn’t alone in adopting new strategies to...
Today's Sponsors
Today's Sponsor